MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$20,874K Short-term investments$4,352K Prepaid expenses andother current assets$1,799K Property and equipment,at cost$5,739K Total current assets$27,025K Property and equipment,net$1,715K Restricted cash$631K Operating leaseright-of-use asset$607K Other long-termassets$55K Less accumulateddepreciation$4,024K Total assets$30,033K Total liabilities andstockholders' equity$30,033K Total stockholders'equity$26,786K Total liabilities$3,247K Accumulated deficit-$428,866K Accumulated othercomprehensive (loss) income-$2K Additional paid-in capital$455,650K Total currentliabilities$2,787K Operating leaseliability, less current...$460K Common stock, 0.0001par value...$4K Accrued liabilities$2,069K Current operating leaseliability$452K Accounts payable$266K
Balance Sheet
source: myfinsight.com

Athira Pharma, Inc. (ATHA)

Athira Pharma, Inc. (ATHA)